首页 | 本学科首页   官方微博 | 高级检索  
     

RNA干扰下调KMT2C基因表达对肝癌细胞HepG2增殖的影响及其机制
引用本文:袁志青,王贵阳,瞿俊文,王晓鹏,李可为. RNA干扰下调KMT2C基因表达对肝癌细胞HepG2增殖的影响及其机制[J]. 肝胆胰外科杂志, 2018, 30(2): 122-133. DOI: 10.11952/j.issn.1007-1954.2018.02.008
作者姓名:袁志青  王贵阳  瞿俊文  王晓鹏  李可为
作者单位:上海交通大学医学院附属仁济医院 胆胰外科,上海 200127
基金项目:国家自然科学青年基金项目(81600491);仁济医院种子基金项目(RJZZ15-012)
摘    要:[摘 要] 目的 探讨组蛋白甲基化转移酶基因KMT2C对肝癌细胞HepG2的增殖影响及其可能的机制。方法 采用shRNA基因干扰技术抑制HepG2细胞中KMT2C基因的表达,采用细胞计数、CCK-8细胞增殖实验以及平板克隆形成实验检测细胞增殖能力,流式细胞仪检测细胞周期变化情况;Western blotting和qRT-PCR检测KMT2C基因干扰前后HepG2细胞中EGFR的表达情况。结果 甲基化转移酶KMT2C基因干扰成功后,HepG2细胞的增殖能力受到明显抑制(P<0.05),细胞周期阻滞在S期;同时细胞内的EGFR蛋白表达量显著下降(P<0.05)。结论 干扰KMT2C基因的表达可以显著抑制肝癌细胞HepG2的增殖,其作用机制可能和EGFR信号通路有关。

关 键 词:KMT2C基因    肝细胞   HepG2细胞系   RNA干扰   细胞增殖  

Effect of down-regulating histone methyltransferase gene KMT2C with shRNA interference onthe proliferation of hepatocellular carcinoma cell line HepG2 and its mechanism #br#
YUAN Zhi-qing,WANG Gui-yang,QU Jun-wen,WANG Xiao-peng,LI Ke-wei.. Effect of down-regulating histone methyltransferase gene KMT2C with shRNA interference onthe proliferation of hepatocellular carcinoma cell line HepG2 and its mechanism #br#[J]. Journal of Hepatopancreatobiliary Surgery, 2018, 30(2): 122-133. DOI: 10.11952/j.issn.1007-1954.2018.02.008
Authors:YUAN Zhi-qing  WANG Gui-yang  QU Jun-wen  WANG Xiao-peng  LI Ke-wei.
Affiliation:Department of Biliary-Pancreatic Surgery, RenjiHospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.
Abstract:Abstractobjective To investigate the effect of down-regulating histone methyltransferases gene KMT2Cwith shRNA interference on the proliferation of hepatocellular carcinoma cell line HepG2 and its mechanism.Methods RNA interference method was used to down-regulate KTM2C expression in HepG2. The cellproliferation was measured by cell counting, CCK-8 kit and colony formation assay and flow cytometry wereperformed to analyze the cell cycle. Western blotting were used to detect the expression of KMT2C and EGFRin HepG2 before and after the RNA interference. Results After successful down-regulation of KMT2C, theproliferation of HepG2 was obviously inhibited (P<0.05) and the cell cycle was blocked in S phase. At the sametime, the EGFR protein expression level was significantly decreased (P<0.05). Conclusion Down-regulation ofKMT2C can inhibit the proliferation of HepG2, which the EGFR signal pathway may be involved.
Keywords:KMT2C gene   hepatocellular carcinoma   HepG2 cell line   RNA interference   cell proliferation  
本文献已被 CNKI 等数据库收录!
点击此处可从《肝胆胰外科杂志》浏览原始摘要信息
点击此处可从《肝胆胰外科杂志》下载全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号